Showing 951-960 of 8921 results for "".
Special Report: COVID-19: Surgeons Support Front Lines, How to Cope
https://practicaldermatology.com/topics/practice-management/special-report-covid-19-surgeons-support-front-lines-how-to-cope/19757/The AAFPRS calls on surgeons to consider donating PPE and supplies like ventilators and beds, as nurses call for more preparation for COVID-19. Experts offer strategies for coping with the current environment and planning ahead. Although the AAD Annual Meeting has been cancelled, voting for new offiDifferentiating Atopic Dermatitis From Psoriasis and CTCL
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/differentiating-atopic-dermatitis-from-psoriasis-and-ctcl/48778/Christopher Bunick, MD, FAAD, discusses the overlap in gene expression and cytokine signaling between atopic dermatitis and psoriasis, the possibility of CTCL mimicking atopic dermatitis, and the utility of a skin biopsy in some cases to differentiate.Science of Skincare Summit 2024: Grab-Bag- Current Topics in Derm
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-grab-bag-current-topics-in-derm/29453/Jennifer Soung, MD, an assistant professor of dermatology at Baylor College of Medicine, and Raja Sivamani, MD, MS, a dermatologist at University of California Davis, join Drs. Todd Schlesinger, James Del Rosso, DO, and Neal Bhatia, MD, for a short discussion about a number of current topics in dermTreating Non-melanoma Skin Cancer: What’s New and Exciting
https://practicaldermatology.com/conferences/scale-2023/treating-non-melanoma-skin-cancer-whats-new-and-exciting/20201/Dermatologists have a host of new tools for treating advanced basal and squamous cell carcinomas. Todd Schlesinger, MD, discusses hedgehog pathway inhibitors and immunotherapy and their growing role in treating non-melanoma skin cancers.DermWireTV: USPS Task Force Skin Cancer Screening Update; The 4th Annual San Diego Dermatology Symposium; Upcoming National Botox Day, Plus More
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-usps-task-force-skin-cancer-screening-update-the-4th-annual-san-diego-dermatology-symposium-upcoming-national-botox-day-plus-more/20155/The United States Preventive Services Task Force says more research is needed before recommending screening for skin cancer in people without symptoms, an update on the Fourth Annual San Diego Dermatology Symposium, plus more top news in this episode of DermWireTV.Warts and All: Treating and Assessing Warts During COVID-19
https://practicaldermatology.com/series/dermatology-dispatches/warts-and-all-treating-and-assessing-warts-during-covid-19/19774/Many warts can be safely treated at home during the COVID-19 pandemic, but new onset warts that are changing colors or bleeding could be squamous cell carcinomas and may require evaluation, explains Neal Bhatia, MD.First Cell-Based Gene Therapy for RDEB
https://practicaldermatology.com/series/dermwire-tv/first-cell-based-gene-therapy-for-rdeb/35742/In this week's DermwireTV, the FDA approves the first cell-based gene therapy for recessive dystophic epidermolysis bullosa (RDEB); a new acne scar treatment using focal point technology is cleared in the US; and in our “Updates on Skin Cancer” feature, we hear about the advantages of 40-GEP testingHow Incyte Is Following the Science to Address Unmet Needs in Immune-Mediated Skin Conditions
https://practicaldermatology.com/topics/infections-infectious-disease/how-incyte-is-following-the-science-to-address-unmet-needs-in-immune-mediated-skin-conditions/19945/Ahmad Naim, MD, Vice President of US Medical Affairs at Incyte, shares how the company’s discovery expertise in immunology is fueling research aimed at delivering innovative medicines that address the unmet needs of people living with immune-mediated dermatologic conditions, including atopic dermatiEmerging Insights into the Immunologic Subtypes of Atopic Dermatitis in Children
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37157/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, discusses new understandings regarding the immunologic subtypes of atopic dermatitis and how they should influence treatment selection.SCALE 2024: Listen as Dr. Joel Cohen Interviews Dr. James Q. Del Rosso on Innovative Therapies
https://practicaldermatology.com/error/404/James Q. Del Rosso, DO, joins Joel Cohen, MD, to discuss innovation in the world of acne and rosacea, atopic dermatitis, psoriasis, alopecia areata, hidradenitis suppurativa, vitiligo, and more at Music City SCALE.